دورية أكاديمية

Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum Meningiomas.

التفاصيل البيبلوغرافية
العنوان: Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent AKT1 E17K Mutations in Foramen Magnum Meningiomas.
المؤلفون: Williams, Sally R., Juratli, Tareq A., Castro, Brandyn A., Lazaro, Tyler T., Gill, Corey M., Nayyar, Naema, Strickland, Matthew R., Babinski, Melanie, Johnstone, Sarah E., Frosch, Matthew P., Silverman, Ian M., Ely, Heather A., Kaplan, Alexander B., D'Andrea, Megan R., Bihun, Ivanna V., Hoang, Kaitlin, Batchelor, Emily, Christiansen, Jason, Cahill, Daniel P., Barker II, Frederick G.
المصدر: Journal of Neurological Surgery. Part B. Skull Base; 2019, Vol. 80 Issue 6, p562-567, 6p
مصطلحات موضوعية: MENINGIOMA, INFRATENTORIAL brain tumors, CEREBELLOPONTILE angle, ARACHNOID cysts, GENE rearrangement, GENE fusion, ANATOMICAL variation
مستخلص: Objective  Posterior fossa meningiomas are surgically challenging tumors that are associated with high morbidity and mortality. We sought to investigate the anatomical distribution of clinically actionable mutations in posterior fossa meningioma to facilitate identifying patients amenable for systemic targeted therapy trials. Methods  Targeted sequencing of clinically targetable AKT1 , SMO , and PIK3CA mutations was performed in 61 posterior fossa meningioma using Illumina NextSeq 500 to a target depth of >500 × . Samples were further interrogated for 53 cancer-relevant RNA fusions by the Archer FusionPlex panel to detect gene rearrangements. Results   AKT 1 (E17K) mutations were detected in five cases (8.2%), four in the foramen magnum and one in the cerebellopontine angle. In contrast, none of the posterior fossa tumors harbored an SMO (L412F) or a PIK3CA (E545K) mutation. Notably, the majority of foramen magnum meningiomas (4/7, 57%) harbored an AKT1 mutation. In addition, common clinically targetable gene fusions were not detected in any of the cases. Conclusion  A large subset of foramen magnum meningiomas harbor AKT1 E17K mutations and are therefore potentially amenable to targeted medical therapy. Genotyping of foramen magnum meningiomas may enable more therapeutic alternatives and guide their treatment decision process. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Neurological Surgery. Part B. Skull Base is the property of Thieme Medical Publishing Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:21936331
DOI:10.1055/s-0038-1676821